Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Vetigenics |
Description | Vision Team Our Technology Partnerships News Contact Vision To improve the lives of companion animals through advanced, science-based medicine Mission To develop |
Keywords | N/A |
WebSite | vetigenics.com |
Host IP | 162.241.24.212 |
Location | United States |
Site | Rank |
US$1,697,424
Last updated: 2023-05-11 06:10:57
vetigenics.com has Semrush global rank of 6,235,510. vetigenics.com has an estimated worth of US$ 1,697,424, based on its estimated Ads revenue. vetigenics.com receives approximately 195,857 unique visitors each day. Its web server is located in United States, with IP address 162.241.24.212. According to SiteAdvisor, vetigenics.com is safe to visit. |
Purchase/Sale Value | US$1,697,424 |
Daily Ads Revenue | US$1,567 |
Monthly Ads Revenue | US$47,006 |
Yearly Ads Revenue | US$564,067 |
Daily Unique Visitors | 13,058 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
vetigenics.com. | A | 7199 | IP: 162.241.24.212 |
vetigenics.com. | NS | 86400 | NS Record: ns1.bluehost.com. |
vetigenics.com. | NS | 86400 | NS Record: ns2.bluehost.com. |
vetigenics.com. | MX | 14400 | MX Record: 0 mail.vetigenics.com. |
vetigenics.com. | TXT | 14400 | TXT Record: v=spf1 a mx include:websitewelcome.com ~all |
Team Our Technology Partnerships News Contact Vision To improve the lives of companion animals through advanced, science-based medicine Mission To develop next generation immunotherapies that effectively treat disease and improve the lives of companion animals OUR PURPOSE To focus our passion and energy on discovering better ways to treat cancer and other chronic diseases for all members of the family VETIGENICS ANNOUNCES SECOND DISCOVERY COLLABORATION WITH A MAJOR ANIMAL HEALTH PHARMA Tue, November 8, 2022, 10:00 AM Vetigenics, an animal health biotechnology company, today announced a second discovery collaboration with a major animal health pharmaceutical company for use of the VETIGENICS CANIBODY™ Platform. The aim is to jointly discover and develop novel therapeutic antibodies to treat chronic diseases of companion animals. read more Read More % households own a dog 6,000,000 dogs diagnosed with cancer per year* % Cancer is leading cause of death in 47% of dogs** $ Treatment Costs |
HTTP/1.1 302 Found Date: Thu, 04 Nov 2021 05:22:08 GMT Server: Apache Location: https://vetigenics.com/ Cache-Control: max-age=300 Expires: Thu, 04 Nov 2021 05:27:08 GMT Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 last-modified: Tue, 02 Nov 2021 22:28:12 GMT accept-ranges: bytes content-length: 14705 cache-control: max-age=300 expires: Thu, 04 Nov 2021 05:27:08 GMT vary: Accept-Encoding host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ== x-endurance-cache-level: 2 content-type: text/html date: Thu, 04 Nov 2021 05:22:08 GMT server: Apache |
Domain Name: VETIGENICS.COM Registry Domain ID: 2158833401_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2021-08-18T15:57:11Z Creation Date: 2017-09-01T16:56:41Z Registry Expiry Date: 2022-09-01T16:56:41Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BLUEHOST.COM Name Server: NS2.BLUEHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-19T07:07:20Z <<< |